Modification of the Quality of Life Based on Objective Geriatric Tests
MEGERIA
Pilot Project - Prospective Longitudinal Cohort of Patients Over 70 Years With Malignant Solid Tumors: Modification of Quality of Life Based on Objective Geriatric Tests
2 other identifiers
interventional
76
1 country
1
Brief Summary
The analysis of this study will achieve an improvement in the management of patients over 70 years with adaptation of chemotherapy regimens after analysis of the subject and its psychosocial environment. The analysis of socio-economic impacts will implement actions to optimize the care of the elderly while emphasizing the value of management / cost of care.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable cancer
Started Mar 2013
Longer than P75 for not_applicable cancer
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2013
CompletedFirst Submitted
Initial submission to the registry
August 11, 2016
CompletedFirst Posted
Study publicly available on registry
August 19, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2019
CompletedSeptember 30, 2025
January 1, 2018
6 years
August 11, 2016
September 29, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Measuring quality of life according to geriatric questionnaires
Activities of Daily Living Questionnaire
36 months
Secondary Outcomes (1)
Geriatric Screening Test fragilities and comorbidities
36 months
Study Arms (1)
A-Elderly patients with cancer
OTHERgeriatric care and longitudinal follow up
Interventions
geriatric care and longitudinal follow up
Eligibility Criteria
You may qualify if:
- Patient over 70 years,
- Patient with a solid malignant tumor,
- Patients for whom a first line chemotherapy is theoretically indicated
- Patient chemotherapy naive,
- Performance Index (PS) \<4
You may not qualify if:
- Patient not understanding or do not speak French,
- Patients with any severe psychopathological disorder preventing the completion of the questionnaire or invalidating a priori measures of the questionnaire
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Centre Antoine LACASSAGNE
Nice, 06189, France
MeSH Terms
Conditions
Study Officials
- PRINCIPAL INVESTIGATOR
Véronique MARI, md
Centre Antoine Lacassagne
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 11, 2016
First Posted
August 19, 2016
Study Start
March 1, 2013
Primary Completion
March 1, 2019
Study Completion
April 1, 2019
Last Updated
September 30, 2025
Record last verified: 2018-01